Skip to main content
Log in

The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to investigate the importance of atherosclerosis in the pathogenesis of sudden hearing loss by evaluating the newly discovered markers, serum salusin-α and salusin-β. We also aimed to evaluate atherosclerosis risk factors, such as lipid profile, smoking, body mass index, waist circumference and mean blood pressure of the patients.

Methods

Fifty-two patients diagnosed with sudden hearing loss (study group) and fifty healthy people (control group) were included in the study. Detailed history was taken from the patients and risk factors for atherosclerosis, such as smoking, body mass index, waist circumference, lipid profile, mean blood pressure and serum salusin-α and salusin-β levels, were evaluated. The study group was divided into recovery group (subgroup I) and non-recovery group (subgroup II).

Results

The salusin-β median value was found to be significantly higher in the study group compared to the control group (p < 0.05). The salusin-β median value was found to be significantly higher in subgroup 2 and was found to be a poor prognostic factor (p < 0.05).

Conclusion

From the results obtained in this study, it is thought that salusin-β peptide is increased in patients with sudden hearing loss and it can be evaluated as a poor prognostic factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SM, Fife TD, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146:1–35. https://doi.org/10.1177/0194599812436449

    Article  Google Scholar 

  2. Wen YH, Chen PR, Wu HP (2014) Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 271:1423–1429. https://doi.org/10.1007/s00405-013-2593-y

    Article  PubMed  Google Scholar 

  3. Edizer DT, Çelebi Ö, Hamit B, Baki A, Yiğit Ö (2015) Recovery of idiopathic sudden sensorineural hearing loss. J Internat Adv Otol. https://doi.org/10.5152/iao.2015.1227

    Article  Google Scholar 

  4. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD (2010) Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 120:1011–1021. https://doi.org/10.1002/lary.20873

    Article  PubMed  Google Scholar 

  5. Ciorba A, Hatzopoulos S, Bianchini C, Iannini V, Rosignoli M, Skarzynski H, Aimoni C (2015) Idiopathic sudden sensorineural hearing loss: cardiovascular risk factors do not influence hearing threshold recovery. Acta Otorhinolaryngol Ital 35:103

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, Censules S, Pignataro L (2007) Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 117:547–551. https://doi.org/10.1097/MLG.0b013e31802f3c6a

    Article  PubMed  Google Scholar 

  7. Doherty J, Berliner KI (2013) Idiopathic sudden sensorineural hearing loss: vascular or viral? Otolaryngol-Head Neck Surg 149:914–917. https://doi.org/10.1177/0194599813506546

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T (2013) Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens 2013:1–8. https://doi.org/10.1155/2013/965140

    Article  CAS  Google Scholar 

  9. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y (2003) Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9:1166. https://doi.org/10.1038/nm913

    Article  CAS  PubMed  Google Scholar 

  10. Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, Adachi M, Shichiri M, Miyazaki A (2008) Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 31:463–468. https://doi.org/10.1291/hypres.31.463

    Article  CAS  PubMed  Google Scholar 

  11. Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T (2010) Chronic infusion of salusin-α and-β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212:70–77. https://doi.org/10.1016/j.atherosclerosis.2010.04.027

    Article  CAS  PubMed  Google Scholar 

  12. Suzuki H, Koizumi H, Ohkubo J, Hohchi N, Ikezaki S, Kitamura T (2016) Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 273:3101–3107. https://doi.org/10.1007/s00405-016-3930-8

    Article  PubMed  Google Scholar 

  13. Sheehy JL (1960) Vasodilator therapy in sensory-neural hearing loss. Laryngoscope 70:885–914. https://doi.org/10.1288/00005537-196007000-00002

    Article  CAS  PubMed  Google Scholar 

  14. Sato H, Kawagishi K (2014) Labyrinthine artery detection in patients with idiopathic sudden sensorineural hearing loss by 7-T MRI. Otolaryngology-Head Neck Surg 150:455–459. https://doi.org/10.1177/0194599813517990

    Article  Google Scholar 

  15. Mosnier I, Stepanian A, Baron G, Bodenez C, Robier A, Meyer B, Fraysse B, Bertholon P, Defay F, Ameziane N, Ferrary E, Sterkers O (2011) Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurotol 16:55–66. https://doi.org/10.1159/000312640

    Article  Google Scholar 

  16. Nakayama C, Shichiri M, Sato K, Hirata Y (2009) Expression of prosalusin in human neuroblastoma cells. Peptides 30:1362–1367. https://doi.org/10.1016/j.peptides.2009.03.021

    Article  CAS  PubMed  Google Scholar 

  17. Liu J, Ren YG, Zhang LH, Tong YW, Kang L (2015) Serum salusin-β levels are associated with the presence and severity of coronary artery disease. J Inv Med Off Pub Am Feder Clin Res 63:632–635. https://doi.org/10.1097/JIM.0000000000000184

    Article  CAS  Google Scholar 

  18. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M (2011) The roles of salusins in atherosclerosis and related cardiovascular diseases. J Am Soc Hypertens 5:359–365. https://doi.org/10.1016/j.jash.2011.06.003

    Article  CAS  PubMed  Google Scholar 

  19. Ti Y, Wang F, Wang ZH, Wang XL, Zhang W, Zhang Y, Bu PL (2012) Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. J Hum Hypertens 26:603–609. https://doi.org/10.1038/jhh.2011.71

    Article  CAS  PubMed  Google Scholar 

  20. Aydin S, Aydin S (2014) Salusin-alpha and-beta expression in heart and aorta with and without metabolic syndrome. Biotech Histochem 89:98–103. https://doi.org/10.3109/10520295.2013.821167

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sena Genç Elden.

Ethics declarations

Conflict of ınterest

None.

Ethics approval

Sakarya University Ethical Committee, Ethical Number: 16214662/050.01.04/33, Ethical Date:29.03.2017.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genç Elden, S., Yılmaz, M.S., Altındiş, M. et al. The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis. Eur Arch Otorhinolaryngol 279, 1311–1316 (2022). https://doi.org/10.1007/s00405-021-06804-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06804-7

Keywords

Navigation